Microparticle-Embedded Cell Spheroids for Higher EV Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing extracellular vesicles suffer from low yield efficiency and limited tissue regenerative functions, particularly in two-dimensional cell cultures, which often result in nutrient deprivation at the center of cell spheroids.
Innovation Solution
A method involving the preparation of microparticles from polymers like PLGA, gelatin, or hyaluronic acid, loading differentiation stimulating factors such as TGF-β1, and embedding these microparticles into cell spheroids formed in adhesion-inhibited microwells to enhance extracellular vesicle production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional 3D cell spheroid culture method is used, then cell culture in bulk is easier, but a necrosis zone forms at the center due to poor nutrient supply
Solution Approach 1:
The patent introduces microparticles as intermediary carriers that deliver differentiation stimulating factors to cells within the spheroid. These microparticles act as mediators between the external environment and the cells, enabling controlled factor delivery without direct contact, thus maintaining cell health while enhancing EV production.
Solution Approach 2:
The patent changes the physical and chemical parameters of the culture system by incorporating microparticles with specific properties (size, material composition, factor loading capacity). This modifies the nutrient and factor distribution parameters within the spheroid, preventing necrosis while maintaining high EV production.
2Ease of manufacture
If two-dimensional cell culture is used, then cell culture is simpler, but extracellular vesicle yield efficiency is low
Solution Approach 1:
The patent transitions from 2D monolayer culture to 3D spheroid culture by embedding cells in microparticles. This dimensional change creates a more physiologically relevant structure that naturally enhances EV production while maintaining operational simplicity through standardized microparticle formulations.
3Reliability
If 3D cell spheroid culture is used, then tissue regenerative functions are improved, but nutrient supply to the center becomes insufficient
Solution Approach 1:
The patent segments the nutrient delivery system by using microparticles that can penetrate and distribute within the spheroid structure. This segmentation allows localized delivery of differentiation factors to different regions of the spheroid, ensuring adequate supply to the center while maintaining the beneficial 3D structure for tissue regeneration.
Data Source
AI summary
The present invention relates to an extracellular vesicle mass production method using a cell spheroid embedded with a microparticle having a differentiation stimulating factor supported therein, and the extracellular vesicle obtained through the production method has the effect of regenerating a tissue, in particular, a cartilage tissue, and, thus, can be used to treat diseases related to tissue regeneration and cartilage by utilizing such effect.